MFRBX
Price
$53.55
Change
+$0.30 (+0.56%)
Updated
Sep 26 closing price
Net Assets
8.15B
VITSX
Price
$159.28
Change
+$1.00 (+0.63%)
Updated
Sep 26 closing price
Net Assets
1.95T
Interact to see
Advertisement

MFRBX vs VITSX

Header iconMFRBX vs VITSX Comparison
Open Charts MFRBX vs VITSXBanner chart's image
MFS Research B
Price$53.55
Change+$0.30 (+0.56%)
VolumeN/A
Net Assets8.15B
Vanguard Total Stock Market Idx I
Price$159.28
Change+$1.00 (+0.63%)
VolumeN/A
Net Assets1.95T
MFRBX vs VITSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MFRBX vs. VITSX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFRBX is a Buy and VITSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.95T vs. MFRBX (8.15B). VITSX pays higher dividends than MFRBX: VITSX (1.17) vs MFRBX (0.00). MFRBX was incepted earlier than VITSX: MFRBX (32 years) vs VITSX (28 years). MFRBX (1.52) is less costly to investors than VITSX (0.03). MFRBX is a more actively managed with annual turnover of: 20.00 vs. VITSX (2.00). MFRBX has a lower initial minimum investment than VITSX: MFRBX (1000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 15.64 vs. MFRBX (0.47). VITSX return over 5 years is better than : 96.60 vs. MFRBX (25.67).
MFRBXVITSXMFRBX / VITSX
Total Expense Ratio1.520.035,067%
Annual Report Gross Expense Ratio1.520.035,067%
Fund Existence32 years28 years-
Gain YTD9.59912.97774%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets8.15B1.95T0%
Annual Yield % from dividends0.001.17-
Returns for 1 year0.4715.643%
Returns for 3 years30.5180.3238%
Returns for 5 years25.6796.6027%
Returns for 10 years63.69250.7525%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATOS0.860.04
+5.12%
Atossa Therapeutics
RNAZ10.170.25
+2.52%
TransCode Therapeutics Inc
PFGC104.301.30
+1.26%
Performance Food Group Company
ALRS22.620.08
+0.35%
Alerus Financial Corp
TMC6.36-0.20
-3.05%
TMC the metals company